The 2005 scientific sessions of the American College of Cardiology (ACC, Bethesda, Maryland), held here in March, highlighted new developments in the rapidly growing areas of drug-eluting stents and implantable cardioverter defibrillators (ICDs), two of the most rapidly growing segments of the interventional cardiology market.